Literature DB >> 8217053

Influence of aminophylline and 8-(p-sulfophenyl)theophylline on the anticonvulsive action of diphenylhydantoin, phenobarbital, and valproate against maximal electroshock-induced convulsions in mice.

K Borowicz1, M Kozicka, Z Kleinrok, S J Czuczwar.   

Abstract

Aminophylline (theophylline2.ethylenediamine) in the dose of 12.5 mg/kg (i.p.) was ineffective upon all antiepileptic drugs studied and at the higher dose of 25 mg/kg, impaired the anticonvulsant action of phenobarbital and valproate against maximal electroshock in mice. The protection offered by diphenylhydantoin was diminished by aminophylline at 50 mg/kg (0.238 mmol of anhydrous theophylline/kg). In contrast, 8-(p-sulfophenyl)theophylline (a theophylline derivative unable to cross the blood-brain barrier) in the dose of 80 mg/kg (0.238 mmol/kg) did not influence the protective activity of diphenylhydantoin, phenobarbital, and valproate. It might be concluded that the aminophylline-induced impairment of the anticonvulsant action of common antiepileptic drugs results from the central effects of this methylxanthine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217053     DOI: 10.1007/bf01245345

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  23 in total

1.  Comparative assays of antiepileptic drugs in mice and rats.

Authors:  E A SWINYARD; W C BROWN; L S GOODMAN
Journal:  J Pharmacol Exp Ther       Date:  1952-11       Impact factor: 4.030

Review 2.  Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients.

Authors:  S J Czuczwar; Z Kleinrok
Journal:  Pharmacol Res       Date:  1990 Nov-Dec       Impact factor: 7.658

3.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

4.  Differential effects of agents enhancing purinergic transmission upon the antielectroshock efficacy of carbamazepine, diphenylhydantoin, diazepam, phenobarbital, and valproate in mice.

Authors:  S J Czuczwar; B Szczepanik; A Wamil; W Janusz; Z Kleinrok
Journal:  J Neural Transm Gen Sect       Date:  1990

5.  Caffeine antagonizes several central effects of diazepam.

Authors:  P Polc; E P Bonetti; L Pieri; R Cumin; R M Angioi; H Möhler; W E Haefely
Journal:  Life Sci       Date:  1981-05-18       Impact factor: 5.037

6.  Potentiation of arginine-induced glucagon secretion by adenosine.

Authors:  B Petrack; A J Czernik; J Ansell; J Cassidy
Journal:  Life Sci       Date:  1981-06-08       Impact factor: 5.037

7.  Pharmacodynamic profile of isbufylline, a new antibronchospastic xanthine devoid of central excitatory actions.

Authors:  S Manzini; S Meini; A Giachetti; L Beani; P A Borea; T Antonelli; L Ballati; C Bacciarelli
Journal:  Arzneimittelforschung       Date:  1990-11

8.  Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice.

Authors:  P Wlaz; Z Rolinski; Z Kleinrok; S J Czuczwar
Journal:  Epilepsia       Date:  1993 Mar-Apr       Impact factor: 5.864

9.  Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents.

Authors:  S J Czuczwar; W Janusz; A Wamil; Z Kleinrok
Journal:  Eur J Pharmacol       Date:  1987-12-15       Impact factor: 4.432

10.  Evidence for a role of cyclic AMP in neuromuscular transmission.

Authors:  A L Goldberg; J J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

View more
  2 in total

1.  Influence of a potential anti-asthmatic drug, CR 2039, upon the anticonvulsive activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.

Authors:  S J Czuczwar; M Gasior; M Kozicka; T Pietrasiewicz; W A Turski; Z Kleinrok
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice.

Authors:  P Tutka; W A Turski; Z Kleinrok; S J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.